ITGB3 and relapsing-remitting multiple sclerosis: While functional and protein-level validation were beyond the scope of this work, our integrated approach establishes a solid basis for subsequent studies investigating PTN–ITGB3 signaling mechanisms in immune cells from RRMS patients.